Johnson & Johnson
XBER:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
XBER:JNJ
Watchlist
Price: 175.76 EUR Market Closed
Market Cap: 423.6B EUR

Profitability Summary

Johnson & Johnson's profitability score is 63/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

63/100
Profitability
Score
63/100
Profitability
Score

Margins

Earnings Waterfall
Johnson & Johnson

Margins Comparison
Johnson & Johnson Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
210.8B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
95.4B EUR
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
109.7B USD
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
71.8B GBP
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Johnson & Johnson Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
210.8B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
95.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
109.7B USD
Loading...
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
71.8B GBP
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Johnson & Johnson

Last Value
3-Years Average
FCF Margin
Conversion Rate